Health Catalyst EBITDA Margin 2018-2025 | HCAT

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Health Catalyst (HCAT) over the last 10 years. The current EBITDA margin for Health Catalyst as of March 31, 2025 is .
Health Catalyst EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2025-03-31 $0.31B $-0.02B -6.43%
2024-12-31 $0.31B $-0.03B -8.14%
2024-09-30 $0.30B $-0.04B -13.58%
2024-06-30 $0.30B $-0.05B -17.67%
2024-03-31 $0.30B $-0.07B -24.24%
2023-12-31 $0.30B $-0.08B -28.38%
2023-09-30 $0.29B $-0.09B -30.00%
2023-06-30 $0.28B $-0.11B -37.32%
2023-03-31 $0.28B $-0.10B -36.17%
2022-12-31 $0.28B $-0.09B -32.61%
2022-09-30 $0.27B $-0.10B -35.29%
2022-06-30 $0.27B $-0.09B -34.59%
2022-03-31 $0.26B $-0.09B -36.47%
2021-12-31 $0.24B $-0.10B -39.09%
2021-09-30 $0.23B $-0.09B -39.83%
2021-06-30 $0.22B $-0.08B -36.57%
2021-03-31 $0.20B $-0.07B -34.17%
2020-12-31 $0.19B $-0.07B -36.70%
2020-09-30 $0.18B $-0.05B -29.05%
2020-06-30 $0.17B $-0.05B -31.58%
2020-03-31 $0.17B $-0.05B -30.91%
2019-12-31 $0.16B $-0.05B -29.03%
2019-06-30 $0.11B $-0.03B -30.48%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.278B $0.307B
Health Catalyst Inc. is a provider of data and analytics technology and services to healthcare organizations. Health Catalyst Inc. is based in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.023B 58.55
Doximity (DOCS) United States $11.285B 52.24
Hims & Hers Health (HIMS) United States $11.252B 116.91
Tempus AI (TEM) United States $10.318B 0.00
IRhythm Technologies (IRTC) United States $4.301B 0.00
Inspire Medical Systems (INSP) United States $4.107B 64.17
Hinge Health (HNGE) United States $3.444B 0.00
Privia Health (PRVA) United States $2.573B 175.83
Enovis (ENOV) United States $2.053B 11.45
Phreesia (PHR) United States $1.706B 0.00
Schrodinger (SDGR) United States $1.593B 0.00
Azenta (AZTA) United States $1.563B 72.66
10x Genomics (TXG) United States $1.554B 0.00
Clover Health Investments (CLOV) United States $1.552B 0.00
Omnicell (OMCL) United States $1.395B 24.60
Evolent Health (EVH) United States $1.318B 112.30
Claritev (CTEV) United States $0.783B 0.00
Fulgent Genetics (FLGT) United States $0.595B 0.00
Standard BioTools (LAB) United States $0.513B 0.00
Veradigm (MDRX) United States $0.498B 0.00
Butterfly Network (BFLY) United States $0.462B 0.00
Talkspace (TALK) United States $0.460B 137.50
Outset Medical (OM) United States $0.365B 0.00
TruBridge (TBRG) United States $0.345B 765.33
Nyxoah SA (NYXH) Belgium $0.264B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.250B 0.00
KORU Medical Systems (KRMD) United States $0.172B 0.00
American Well (AMWL) United States $0.131B 0.00
EUDA Health Holdings (EUDA) Singapore $0.119B 0.00
Pulmonx (LUNG) United States $0.107B 0.00
MDxHealth SA (MDXH) Belgium $0.103B 0.00
CareCloud (CCLD) United States $0.102B 3.90
Zepp Health (ZEPP) Netherlands $0.088B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.083B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.076B 0.00
111 (YI) China $0.065B 0.00
P3 Health Partners (PIII) United States $0.045B 0.00
HeartBeam (BEAT) United States $0.043B 0.00
Zhongchao (ZCMD) China $0.028B 0.00
Precipio (PRPO) United States $0.024B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.010B 0.00
MSP Recovery (MSPR) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Movano (MOVE) United States $0.005B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00